Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, Missouri, USA.
Diabetes. 2012 Aug;61(8):2054-65. doi: 10.2337/db11-1723. Epub 2012 Jun 29.
Type 1 diabetes involves both T helper (Th)1 and Th17 cells. While the mechanisms underlying the control of Th1 cells are relatively well defined, those operating modulation of Th17 cells remain unknown. Moreover, given that Th17 cells are plastic and can drive disease as stable or convertible T cells, effective approaches to counter type 1 diabetes would have to alter Th17 function under both circumstances. Herein, we genetically incorporated the BDC2.5-reactive p79 mimotope into an Ig molecule, and the resulting Ig-p79 was used to investigate Th17 tolerance. Accordingly, diabetogenic BDC2.5 Th17 cells were transferred into NOD mice under convertible or stable conditions and their fate was evaluated upon induction of tolerance and disease suppression by Ig-p79. The findings show that convertible (Th17 to Th1) cells display downregulation of the chemokine (C-X-C motif) receptor 3 that was associated with diminished T-box transcription factor T-bet expression, retention in the spleen, and inhibition of trafficking to the pancreas. In contrast, stable Th17 cells downregulated orphan nuclear receptor ROR-γt but increased Fas ligand expression and died by apoptosis. Thus, the final signature transcription factor shapes the mechanism of tolerance in plastic Th17 cells. These findings suggest that effective strategies against type 1 diabetes will require regimens that could drive both mechanisms of tolerance to overcome the disease.
1 型糖尿病涉及辅助性 T 细胞(Th)1 和 Th17 细胞。虽然 Th1 细胞调控的机制相对明确,但调节 Th17 细胞的机制仍不清楚。此外,由于 Th17 细胞具有可塑性,可以作为稳定或可转化的 T 细胞驱动疾病,因此有效治疗 1 型糖尿病的方法必须在这两种情况下改变 Th17 功能。在此,我们将 BDC2.5 反应性 p79 模拟物基因整合到免疫球蛋白分子中,并用所得的 Ig-p79 来研究 Th17 耐受。相应地,在可转化(Th17 向 Th1 转化)或稳定条件下将致糖尿病的 BDC2.5 Th17 细胞转移到 NOD 小鼠中,并在通过 Ig-p79 诱导耐受和抑制疾病时评估其命运。研究结果表明,可转化(Th17 向 Th1 转化)细胞表现出趋化因子(C-X-C 基序)受体 3 的下调,这与 T 盒转录因子 T-bet 表达减少、在脾脏中的保留以及向胰腺的迁移抑制有关。相比之下,稳定的 Th17 细胞下调孤儿核受体 ROR-γt,但增加 Fas 配体表达并通过细胞凋亡而死亡。因此,最终的特征转录因子决定了可塑性 Th17 细胞耐受的机制。这些发现表明,针对 1 型糖尿病的有效策略将需要能够驱动两种耐受机制的方案来克服该疾病。